medigraphic.com
ISSN 0035-0052 (Print)

2025, Number 3

<< Back Next >>

Rev Mex Pediatr 2025; 92 (3)

Perception of Mexican pediatricians about the limitations to achieving a timely diagnosis in patients with solid tumors

Abaunza-Tapia CG, Rendón-Macías ME, Canseco-Herrera M, Villasís-Keever MÁ, Alaníz-Manjarrez ICJ, García-Pérez A, Gómez-Alvarez A, Montesinos-Ramírez C

Language: Spanish
References: 35
Page: 97-106
PDF size: 414.17 Kb.


ABSTRACT

Introduction: in low- and middle-income countries, childhood cancer mortality remains high. The objective of this study is to assess Mexican pediatricians' perceptions of the limitations and opportunities for obtaining timely diagnoses of solid tumors in primary care settings. Material and methods: a validated survey, administered online, consists of 20 questions about the limitations and opportunities for obtaining a timely diagnosis in children and adolescents with solid tumors. Results: 194 pediatricians responded to the survey; the majority agreed on the factors considered significant in diagnostic delays. Specifically, 74-89% of participants agreed that low clinical suspicion, nonspecific signs and symptoms, and poor communication with adolescent patients were limiting clinical factors. 72-76% considered short consultation times, the lack of availability of imaging studies, the limited of social security coverage, and family problems limit timely diagnosis. In areas of opportunity, pediatricians agree that it is important to perform specific maneuvers (checking the red reflex, testicular palpation and search for abdominal masses) and to request imaging studies when specific clinical signs are detected. Conclusions: this study identifies the limitations that pediatricians perceive in the timely diagnosis of pediatric patients with solid tumors. The results can serve as a basis for implementing educational strategies for primary care physicians.


REFERENCES

  1. Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Pediatric solid tumors. In: Abeloff's Clinical Oncology. Elsevier; 2020. p. 1703-1747.e11. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/B978032347674400092X

  2. Pfister SM, Reyes-Múgica M, Chan JKC, Hasle H, Lazar AJ, Rossi S et al. A summary of the inaugural WHO classification of pediatric tumors: transitioning from the optical into the molecular era. Cancer Discov. 2022; 12(2): 331-355.

  3. Cotache-Condor C, Kantety V, Grimm A, Williamson J, Landrum KR, Schroeder K et al. Determinants of delayed childhood cancer care in low- and middle-income countries: a systematic review. Pediatr Blood Cancer. 2023; 70(3): e30175.

  4. Bosetti C, Bertuccio P, Chatenoud L, Negri E, Levi F, La Vecchia C. Childhood cancer mortality in Europe, 1970-2007. Eur J Cancer. 2010; 46(2): 384-394.

  5. Rivera-Luna R, Zapata-Tarres M, Shalkow-Klincovstein J, Velasco-Hidalgo L, Olaya-Vargas A, Finkelstein-Mizrahi N et al. The burden of childhood cancer in Mexico: Implications for low- and middle-income countries. Pediatr Blood Cancer. 2017; 64(6).

  6. Bragonier R, Cordey E. Suspected childhood cancer fast track: increasing referrals, diminishing returns. Arch Dis Child. 2015; 100(9): 900-901.

  7. World Health Organization. The global initiative for childhood cancer. Disponible en: https://www.who.int/initiatives/the-global-initiative-for-childhood-cancer

  8. Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer: a review. Cancer. 2007; 110(4): 703-713.

  9. Chen J, Mullen CA. Patterns of diagnosis and misdiagnosis in pediatric cancer and relationship to survival. J Pediatr Hematol Oncol. 2017; 39(3): e110-e115.

  10. Vasquez L, Oscanoa M, Tello M, Tapia E, Maza I, Geronimo J. Factors associated with the latency to diagnosis of childhood cancer in Peru. Pediatr Blood Cancer. 2016; 63(11): 1959-1965.

  11. Dirección General de Epidemiología, Secretaría de Salud. Registro de cáncer en niños y adolescentes. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/632369/RNCA_2019.pdf

  12. Fajardo-Gutiérrez A, González-Miranda G, Pachuca-Vázquez A, Allende-López A, Fajardo-Yamamoto LM, Rendón-Macías ME. Cancer incidence and mortality in children in the Mexican Social Security Institute (1996-2013). Salud Publica Mex. 2016; 58(2): 162-170.

  13. Feltbower RG, Lewis IJ, Picton S, Richards M, Glaser AW, Kinsey SE et al. Diagnosing childhood cancer in primary care – a realistic expectation? Br J Cancer. 2004; 90(10): 1882-1884.

  14. Saatci D, Oke J, Harnden A, Hippisley-Cox J. Identifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers: a population-based nested case-control study. Br J Cancer. 2024; 131(6): 1032-1042.

  15. Kukal K, Dobrovoljac M, Boltshauser E, Ammann RA, Grotzer MA. Does diagnostic delay result in decreased survival in paediatric brain tumours? Eur J Pediatr. 2009; 168(3): 303-310.

  16. Brasme JF, Grill J, Gaspar N, Oberlin O, Valteau-Couanet D, Chalumeau M. Evidence of increasing mortality with longer time to diagnosis of cancer: Is there a paediatric exception? Eur J Cancer. 2014; 50(4): 864-866.

  17. Ferrari A, Lo Vullo S, Giardiello D, Veneroni L, Magni C, Clerici CA et al. The sooner the better? How symptom interval correlates with outcome in children and adolescents with solid tumors: regression tree analysis of the findings of a prospective study: delay in diagnosis and outcome. Pediatr Blood Cancer. 2016; 63(3): 479-485.

  18. Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015; 112 (Suppl 1): S92-S107.

  19. Kirchherr J, Charles K. Enhancing the sample diversity of snowball samples: recommendations from a research project on anti-dam movements in Southeast Asia. PLoS One. 2018; 13(8): e0201710.

  20. Ehrlich BS, McNeil MJ, Pham LTD, Chen Y, Rivera J, Acuna C et al. Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Oncol. 2023; 24(9): 967-977.

  21. Pinsuwan C, Santong C, Chainansamit SO, Komvilaisak P, Sirikarn P, Phimha S et al. Trends in incidence and survival of childhood cancers in Khon Kaen, Thailand (2000-2019): a population-based Khon Kaen Cancer Registry study. BMC Public Health. 2024; 24(1): 1255.

  22. Haimi M, Perez-Nahum M, Stein N, Ben Arush MW. The role of the doctor and the medical system in the diagnostic delay in pediatric malignancies. Cancer Epidemiol. 2011; 35(1): 83-89.

  23. Weiser DA, Kaste SC, Siegel MJ, Adamson PC. Imaging in childhood cancer: a society for pediatric radiology and children's oncology group joint task force report. Pediatr Blood Cancer. 2013; 60(8): 1253-1260.

  24. Alvarez EM, Winestone L, McPheeters J, Puccetti D, Wilkes JJ, Henk HJ et al. Factors impacting time to diagnosis in pediatric, adolescent and young adult (AYA) patients with solid tumors. J Clin Oncol. 2019; 37(15_suppl): e21515-e21515.

  25. Leal-Leal CA, Dilliz-Nava H, Flores-Rojo M, Robles-Castro J. First contact physicians and retinoblastoma in Mexico. Pediatr Blood Cancer. 2011; 57(7): 1109-1112.

  26. Loh AHP, Aung L, Ha C, Tan A, Quah TC, Chui C. Diagnostic delay in pediatric solid tumors: a population-based study on determinants and impact on outcomes. Pediatr Blood Cancer. 2012; 58(4): 561-565.

  27. Viswanathan A, Kumar A, Thumallapalli A, Kaushik PS, Aruna kumari BS, Appaji L et al. Rare pediatric malignancies - A twenty-year experience from an oncology institute in South India. Pediatr Hematol Oncol J. 2021; 6(2): 100-104.

  28. Qu LG, Brand NR, Chao A, Ilbawi AM. Interventions addressing barriers to delayed cancer diagnosis in low- and middle-income countries: a systematic review. Oncologist. 2020; 25(9): e1382-e1395.

  29. Mullen CJR, Barr RD, Franco EL. Timeliness of diagnosis and treatment: the challenge of childhood cancers. Br J Cancer. 2021; 125(12): 1612-1620.

  30. Marcinko J, Orkin J, Cohen E, Ho M, Lalloo C, Jiwan A et al. Paediatric Project echo: exploring the educational needs of Ontario healthcare providers with interest in caring for children with medical complexity. Paediatr Child Health. 2018; 23(suppl_1): e5-e6.

  31. Dassi N, Cappellano AM, de Sousa FIS, Puccini RF, da Silva NS, Strufaldi MWL. Unlocking delays: revealing barriers to early diagnosis of childhood central nervous system tumors in an upper-middle-income country. Childs Nerv Syst. 2024; 40(11): 3545-3552. doi: 10.1007/s00381-024-06629-9.

  32. Morgan JE, Walker R, Harden M, Phillips RS. A systematic review of evidence for and against routine surveillance imaging after completing treatment for childhood extracranial solid tumors. Cancer Med. 2020; 9(14): 4949-4961.

  33. Carter NH, Avery AH, Libes J, Lovvorn HN 3rd, Hansen EN. Pediatric solid tumors in resource-constrained settings: a review of available evidence on management, outcomes, and barriers to care. Children (Basel). 2018; 5(11): 143.

  34. Haileamlak A. The challenge of childhood cancer in developing countries. Ethiop J Health Sci. 2016; 26(3): 199-200.

  35. White Y, Castle VP, Haig A. Pediatric oncology in developing countries: challenges and solutions. J Pediatr. 2013; 162(6): 1090-1091.e1.




2020     |     www.medigraphic.com